1. Home
  2. UIS vs LENZ Comparison

UIS vs LENZ Comparison

Compare UIS & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unisys Corporation New

UIS

Unisys Corporation New

HOLD

Current Price

$3.53

Market Cap

220.2M

Sector

Technology

ML Signal

HOLD

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$5.91

Market Cap

198.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UIS
LENZ
Founded
1942
2019
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.2M
198.8M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
UIS
LENZ
Price
$3.53
$5.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$5.67
$44.00
AVG Volume (30 Days)
1.1M
556.6K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,950,100,000.00
$19,088,000.00
Revenue This Year
N/A
$50.42
Revenue Next Year
$2.60
$197.16
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.97
$6.29
52 Week High
$4.98
$50.19

Technical Indicators

Market Signals
Indicator
UIS
LENZ
Relative Strength Index (RSI) 47.40 29.43
Support Level $3.51 N/A
Resistance Level $4.06 $10.42
Average True Range (ATR) 0.30 0.43
MACD -0.10 -0.02
Stochastic Oscillator 3.64 3.26

Price Performance

Historical Comparison
UIS
LENZ

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. maximum of revenue is from CA&I segment.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

Share on Social Networks: